Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials
Authors:
- 1 January 2005
- journal article
- review article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 28 (5) , 385-407
Abstract
Hypertension Research, official publication of the Japanese Society of Hypertension, publishes papers reporting original clinical and experimental research in the field of hypertension and related cardiovascular diseases.Keywords
This publication has 142 references indexed in Scilit:
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Outcome beyond blood pressure control?2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)The American Journal of Cardiology, 2001
- Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)The American Journal of Cardiology, 1997
- Secondary prevention with verapamil after myocardial infarctionThe American Journal of Cardiology, 1990
- Plasma Acid-Base Patterns in Diabetic KetoacidosisNew England Journal of Medicine, 1982
- Effects of treatment in hypertension results of a controlled studyJournal of Chronic Diseases, 1966